홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

D-벤즈페타민

Benzfetamine

HCID 2341
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
101-47-3
표준 SMILES
CC(Cc1ccccc1)N(C)Cc1ccccc1
InChIKey
YXKTVDFXDRQTKV-UHFFFAOYSA-N
분자식
C17H21N
평균 분자량
239.35 g/mol
단동위원소 질량
239.16739967

개요

A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)

이름 및 식별자

우선 이름
Benzfetamine
IUPAC
N-benzyl-N-methyl-1-phenylpropan-2-amine
현지명
D-벤즈페타민
영어명
D-Benzphetamine
분자식
C17H21N
분자량
239.36

이름 및 동의어

RefChem:1078733Benzfetamined-Benzphetamine101-47-3N-benzyl-N-methyl-1-phenylpropan-2-aminedl-Benzphetamine(+/-)-benzphetamineBenzphetamine, (+/-)-QZH832I91BBenzfetamine (INN)(+-)-BenzphetaminwUNII-QZH832I91B
이름 더 보기
D-벤즈페타민*Amphetamine Impurity 31Benzphetamine, racemic mixtureN,α-Dimethyl-N-benzylbenzeneethanaminebenzyl-methyl-(1-methyl-2-phenyl-ethyl)amineN-methyl-1-phenyl-N-(phenylmethyl)propan-2-amineBenzeneethanamine, N,α-dimethyl-N-(phenylmethyl)-
Benzphetamine,N,alpha-Dimethyl-N-(phenylmethyl)benzeneethanamineSCHEMBL678807Benzeneethanamine, N,alpha-dimethyl-N-(phenylmethyl)-DTXSID50859308YXKTVDFXDRQTKV-UHFFFAOYSA-NN-Benzyl-N-methyl-1-phenyl-2-propanamine #C07538

데이터베이스 식별자

CAS
101-47-3
PubChem CID
2341
DTXSID
DTXSID50859308
UNII
QZH832I91B
Nikkaji
J292.236C

물성

구조 계산 물성보충 중

XLogP
4.1
극성 표면적
3.2 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
1
회전 가능 결합 수
5
무거운 원자 수
18
형식 전하
0
복잡도
214

물리화학적 성질

끓는 점
127 °C · 127 °C(Press: 0.2 Torr)
밀도
0.996 · 0.996±0.06 g/cm3(Predicted)
산도 계수 (pKa)
8.88 · 8.88±0.50(Predicted)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

독성 정보

Treatment · 1건

Management of acute amphetamine intoxication is largely symptomatic and includes sedation with a barbiturate. If hypertension is marked, the use of a nitrite or rapidly acting alpha receptor blocking agent should be considered. Acidification of the urine increases amphetamine excretion. (L1712)

Health Effects · 1건

Using large amounts of these drugs can result in a condition known as amphetamine psychosis -- which can result in auditory, visual and tactile hallucinations, intense paranoia, irrational thoughts and beliefs, delusions, and mental confusion.

Exposure RoutesOral. Readily absorbed from the gastro-intestinal tract and buccal mucosa. It Is resistant to metabolism by monoamine oxidase.
Toxicity Summary · 1건

Although the mechanism of action of the sympathomimetic appetite suppressants in the treatment of obesity is not fully known, these medications have pharmacological effects similar to those of amphetamines. Amphetamine and related sympathomimetic medications (such as benzphetamine) are thought to stimulate the release of norepinephrine and/or dopamine from storage sites in nerve terminals in the lateral hypothalamic feeding center, thereby producing a decrease in appetite. This release is mediated by the binding of benzphetamine to centrally located adrenergic receptors.

Signs and SymptomsAcute overdosage may result in restlessness, tremor, tachypnea, confusion, assaultiveness, and panic states.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataLD50: 160 mg/kg (Oral, Rat) (A308)

화학 및 산업

약리 정보

Metabolism/MetabolitesHepatic. Benzphetamine's metabolites include amphetamine and methamphetamine. Half Life: 16 to 31 hours

용도 및 제조

UsesFor the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트